View Section: Company Analysis
Immuneering Rating
IM
IMRX stock is not rated by Eyestock analysis.
The model does not consider the rating of companies that have no revenue
Discover High-rated Companies
View Section: Valuation
IM
Last reporting period 31 Dec, 2023
Updated 01 Nov, 2024
Last price
—
Market cap $B
0.087
Exchange
XNAS - Nasdaq
IM
IMRX stock is not rated by Eyestock analysis.
The model does not consider the rating of companies that have no revenue